公开(公告)号：US20180369798A1

公开(公告)日：2018-12-27

申请号：US16062499

申请日：2016-12-16

Applicant: ACENET INC.

Inventor： Kiyoto TAKAMORI ,  Takekatsu SHIBATA

IPC: B01J31/02 ,  A61K31/14 ,  A61K33/20 ,  C07B61/00 ,  C07C29/48 ,  A61P31/04 ,  C07D219/06 ,  C07C63/06 ,  C07F15/06

Abstract: An object of a first aspect of the present invention is to provide a radical generating catalyst that can generate (produce) radicals under mild conditions. In order to achieve the above object, a first radical generating catalyst according to the first aspect of the present invention is characterized in that it includes ammonium and/or a salt thereof. A second radical generating catalyst according to the first aspect of the present invention is characterized in that it includes an organic compound having Lewis acidic properties and/or Brønsted acidic properties.

公开(公告)号：US20230181628A1

公开(公告)日：2023-06-15

申请号：US17999347

申请日：2021-05-19

Applicant: OSAKA UNIVERSITY

Inventor： Kazutake TSUJIKAWA ,  Kiyoto TAKAMORI ,  Takekatsu SHIBATA

IPC: A61K33/14 ,  A61P35/00 ,  A61P13/10 ,  A61K31/14 ,  A61P15/00 ,  A61P1/00 ,  A61P1/18

CPC classification number: A61K33/14 ,  A61P35/00 ,  A61P13/10 ,  A61K31/14 ,  A61P15/00 ,  A61P1/00 ,  A61P1/18

Abstract: The present invention provides an epithelial cancer therapeutic agent with less side effects. In order to achieve the above object, an epithelial cancer therapeutic agent of the present invention includes: at least one material selected from the group consisting of oxo acid, oxo acid ion, and oxo acid salt, wherein the epithelial cancer therapeutic agent treats or prevents epithelial cancer.